AU7263994A - Novel mutated human and simian immunodeficiency viruses and vaccines containing said viruses - Google Patents

Novel mutated human and simian immunodeficiency viruses and vaccines containing said viruses

Info

Publication number
AU7263994A
AU7263994A AU72639/94A AU7263994A AU7263994A AU 7263994 A AU7263994 A AU 7263994A AU 72639/94 A AU72639/94 A AU 72639/94A AU 7263994 A AU7263994 A AU 7263994A AU 7263994 A AU7263994 A AU 7263994A
Authority
AU
Australia
Prior art keywords
viruses
simian immunodeficiency
vaccines containing
mutated human
novel mutated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72639/94A
Inventor
Einari Aavik
Kai Juhani Ernst Krohn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU7263994A publication Critical patent/AU7263994A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU72639/94A 1993-08-06 1994-08-03 Novel mutated human and simian immunodeficiency viruses and vaccines containing said viruses Abandoned AU7263994A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10278893A 1993-08-06 1993-08-06
US102788 1993-08-06
PCT/FI1994/000335 WO1995004546A1 (en) 1993-08-06 1994-08-03 Novel mutated human and simian immunodeficiency viruses and vaccines containing said viruses

Publications (1)

Publication Number Publication Date
AU7263994A true AU7263994A (en) 1995-02-28

Family

ID=22291675

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72639/94A Abandoned AU7263994A (en) 1993-08-06 1994-08-03 Novel mutated human and simian immunodeficiency viruses and vaccines containing said viruses

Country Status (2)

Country Link
AU (1) AU7263994A (en)
WO (1) WO1995004546A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2731355B1 (en) * 1995-03-08 1997-05-30 Neovacs NOVEL IMMUNOGENS, NOVEL ANTIBODIES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP0814834B2 (en) * 1995-03-08 2009-03-18 Neovacs Non-toxic immunogens derived from a retroviral regulatory protein, antibodies directed against said immunogens, preparation method therefor, and pharmaceutical compositions containing the same
WO1997032983A1 (en) * 1996-03-05 1997-09-12 The Regents Of The University Of California Recombinant live feline immunodeficiency virus and proviral dna vaccines
US6200575B1 (en) 1996-03-07 2001-03-13 Neovacs Non-toxic immunogens derived from a retroviral regulatory protein antibodies preparation process and pharmaceutical compositions comprising them

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3140757B2 (en) * 1989-02-06 2001-03-05 デイナ・フアーバー・キヤンサー・インステイテユート Packaging defective HIV provirus, cell lines and uses thereof
CA2032158C (en) * 1989-05-25 2009-09-15 Helmut Bachmayer Multivalent repressor of gene function
ES2150416T3 (en) * 1990-09-25 2000-12-01 Cantab Pharma Res DEFECTIVE VIRAL VACCINE PRODUCED BY A CELL LINE SUPPLEMENTED IN TRANS.

Also Published As

Publication number Publication date
WO1995004546A1 (en) 1995-02-16

Similar Documents

Publication Publication Date Title
AU5726694A (en) Human immunodeficiency virus decoy
AU4325089A (en) Viral vaccines
CZ197595A3 (en) Vaccine preparations
EP0460565A3 (en) Titanium phthalocyanines and processes for the preparation thereof
ZA936592B (en) Nutrition for persons infected with human immunodeficiency virus
AU4579893A (en) Bone materials
ZA924150B (en) Vaccine for human immunodeficiency virus
EP0631506A4 (en) Selectively deglycosylated human immunodeficiency virus type 1 envelope vaccines.
AU2954692A (en) Medical preparations
AU6551094A (en) Bifunctional nucleosides, oligomers thereof, and methods of making and using the same
AU5848794A (en) Multiple-gene mutants of human immunodeficiency virus (hiv) for vaccine use
AU2966392A (en) Transparent part and use thereof
AU4088697A (en) Postinfection human immunodeficiency virus (hiv) vaccination therapy
AU6715094A (en) Recombinant vaccine
AU7263994A (en) Novel mutated human and simian immunodeficiency viruses and vaccines containing said viruses
AU5836390A (en) Human lymphoma-associated virus
AU6163590A (en) Mutant pseudorabies virus, and vaccines containing the same
AU7516494A (en) Oligomers for modulating human immunodeficiency virus
AU6112890A (en) Application aid and the use thereof
AU3557889A (en) Protective peptides derived from human immunodeficiency virus-1 gp160
AU647559B2 (en) Pyrimidinyl- and triazinyl-salicylamides and their use and preparation
AU3163893A (en) Bicistronic viruses
AU6877991A (en) A method of inactivating human immunodeficiency virus
AU2347692A (en) Recombinant viral vaccine
AU5050490A (en) Human monocyte-macrophage-csf preparations